Structure-activity relationships drug design

Subject Drugs--Design. Drugs--Structure-activity relationships. Drugs—Conformation. Drug Design. Structure-Activity Relationship. [Pg.674]

GR Marshall, CD Barry, HE Bosshard, RA Dammkoehler, DA Dunn. The conformational parameter m drug design The active analog approach. ACS Symp Ser 112 205-226, 1979. JL Fauchere, ed. QSAR Quantitative Structure-Activity Relationships m Drug Design. New York Alan R Liss, 1989, pp 177-181. [Pg.366]

H-bonding Parameterization in Quantitative Structure-Activity Relationships and Drug Design... [Pg.127]

I 6 H-bonding Parameterization in Quantitative Structure-Activity Relationships ef Drug Design Tab. 6.4 X-ray data, H-bond parameters and optimum energies and distances for few ideal complexes [48]. [Pg.140]

Testa, B., Kier, L. B. The concept of molecular structure in structure-activity relationship studies and drug design. Med. Res. Rev. 1991, 11, 35 8. [Pg.150]

P.J. Lewi, Multivariate data analysis in structure-activity relationships. In Drug Design (E.J. Ariens, Ed.), Vol. X. Academic Press, New York, 1980. [Pg.419]

Stimulus Properties of Hallucinogenic Phenalkylamines and Related Designer Drugs Formulation of Structure-Activity Relationships... [Pg.43]

Enzyme inhibitors—Therapeutic use—Testing. 2. Drugs—Design. 3. Enzyme inhibitors— Structure-activity relationships. I. Title. [Pg.280]

Weinstein, H., R. Osman, and J. P. Green. 1979. The Molecular Basis of Structure-Activity Relationships Quantum Chemical Recognition Mechanisms in Drug-Receptor Interactions. In Computer-Assisted Drug Design. E. C. Olson and R. E. Christofferson, eds. American Chemical Society, Washington, D.C. [Pg.83]